Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1987 1
1990 1
1991 7
1992 3
1993 6
1994 3
1995 8
1996 5
1997 7
1998 7
1999 7
2000 10
2001 14
2002 18
2003 13
2004 16
2005 21
2006 29
2007 18
2008 23
2009 20
2010 30
2011 45
2012 64
2013 54
2014 70
2015 60
2016 64
2017 41
2018 41
2019 30
2020 37
2021 67
2022 62
2023 64
2024 52
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

936 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I. André F, et al. Among authors: aksoy s. Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086745 Clinical Trial.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Among authors: aksoy s. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
World neglected tropical diseases day.
Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. Hotez PJ, et al. Among authors: aksoy s. PLoS Negl Trop Dis. 2020 Jan 29;14(1):e0007999. doi: 10.1371/journal.pntd.0007999. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31995572 Free PMC article.
Microbiota in disease-transmitting vectors.
Wang J, Gao L, Aksoy S. Wang J, et al. Among authors: aksoy s. Nat Rev Microbiol. 2023 Sep;21(9):604-618. doi: 10.1038/s41579-023-00901-6. Epub 2023 May 22. Nat Rev Microbiol. 2023. PMID: 37217793 Review.
What constitutes a neglected tropical disease?
Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. Hotez PJ, et al. Among authors: aksoy s. PLoS Negl Trop Dis. 2020 Jan 30;14(1):e0008001. doi: 10.1371/journal.pntd.0008001. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31999732 Free PMC article.
Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.
Saatci O, Alam R, Huynh-Dam KT, Isik A, Uner M, Belder N, Ersan PG, Tokat UM, Ulukan B, Cetin M, Calisir K, Gedik ME, Bal H, Sener Sahin O, Riazalhosseini Y, Thieffry D, Gautheret D, Ogretmen B, Aksoy S, Uner A, Akyol A, Sahin O. Saatci O, et al. Among authors: aksoy s. Cell Death Dis. 2024 Jun 15;15(6):418. doi: 10.1038/s41419-024-06814-3. Cell Death Dis. 2024. PMID: 38879508 Free PMC article.
Cancer Prevalence across Vertebrates.
Compton ZT, Mellon W, Harris VK, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez LN, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Li CI, Zehnder A, Graham TA, Troan BV, Harrison TM, Tollis M, Schiffman JD, Aktipis CA, Abegglen LM, Maley CC, Boddy AM. Compton ZT, et al. Among authors: aksoy s. Cancer Discov. 2025 Jan 13;15(1):227-244. doi: 10.1158/2159-8290.CD-24-0573. Cancer Discov. 2025. PMID: 39445720 Free PMC article.
Cancer Prevalence Across Vertebrates.
Compton ZT, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Compton ZT, et al. Among authors: aksoy s. Res Sq [Preprint]. 2023 Jul 6:rs.3.rs-3117313. doi: 10.21203/rs.3.rs-3117313/v1. Res Sq. 2023. Update in: Cancer Discov. 2025 Jan 13;15(1):227-244. doi: 10.1158/2159-8290.CD-24-0573. PMID: 37461608 Free PMC article. Updated. Preprint.
Tissue spaces are reservoirs of antigenic diversity for Trypanosoma brucei.
Beaver AK, Keneskhanova Z, Cosentino RO, Weiss BL, Awuoche EO, Smallenberger GM, Buenconsejo GY, Crilly NP, Smith JE, Hakim JMC, Zhang B, Bobb B, Rijo-Ferreira F, Figueiredo LM, Aksoy S, Siegel TN, Mugnier MR. Beaver AK, et al. Among authors: aksoy s. Nature. 2024 Dec;636(8042):430-437. doi: 10.1038/s41586-024-08151-z. Epub 2024 Oct 30. Nature. 2024. PMID: 39478231 Free PMC article.
936 results